Skip to main content

AN ADAPTIVE PHASE I/II DOSE ESCALATION TRIAL OF STEREOTACTIC BODY RADIATION THERAPY IN COMBINATION WITH RADIOMODULATING AGENT GC4419 IN LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA

Clinical Trial Grant
Duke Scholars

Administered By

Radiation Oncology

Awarded By

Galera Therapeutics, Inc.

Start Date

September 5, 2019

End Date

August 31, 2021
 

Administered By

Radiation Oncology

Awarded By

Galera Therapeutics, Inc.

Start Date

September 5, 2019

End Date

August 31, 2021